u-When cultured malignant cells derived from rat gliomas (C6 and 9L) and human gliomas (A-172 and T98G) were treated for 4 hours with 1 to 80 um nordihydroguaiaretic acid (NDGA) or 5,8,11,14-eicosatetraynoic acid (ETYA), a dose-dependent inhibition of deoxyribonucleic acid (DNA) synthesis occurred. In a series of three experiments for each cell line, 40 ,M NDGA suppressed ~H-thymidine incorporation in the rat and human glioma lines to an average of less than 3.1% and 5.6% of control uptake (counts per minute), respectively. Incubation with a higher concentration of ETYA (80 ~M) resulted in inhibition of rat and human DNA synthesis to less than 53% and 62% of control levels, respectively. This inhibition was not associated with any loss of cell viability, as judged by trypan blue exclusion studies. Prolonged incubation (for 72 hours) of the rat and human glioma cells with NDGA markedly decreased cell proliferation with no loss of cell viability. The inhibition of human glioma cell division by NDGA was rapidly reversible after incubation for 24 hours and at least partially reversible after incubation for 96 hours. It is concluded that the inhibitors of eicosanoid biosynthesis, NDGA and (to a lesser extent) ETYA, reduce in vitro cell proliferation in two glioma lines from both the rat and human. Since neither indomethacin nor acetylsalicylic acid altered DNA synthesis in these cell lines, this implicates the lipoxygenase products of arachidonic acid metabolism as important positive modulators in glioma cell division. These findings warrant further study in an in vivo system. KEY WORDS 9 glioma 9 eicosanoid 9 nordihydroguaiaretic acid 9 lipoxygenase 9 eicosatetraynoic acid -brain neoplasm 9 arachidonic acid 9 rat T HE eicosanoids, derived from the precursor arachidonic acid, are metabolized via two pathways. The enzyme cyclo-oxygenase produces prostaglandins, prostacyclins, and thromboxanes while lipoxygenase produces hydroxyeicosatetraenoic acid derivatives (HETES) and the leukotrienes (Fig. 1) . These compounds have been found to play a role in tumor promotion, cell proliferation, metastases, and immune surveillance. ~''7~ Eicosanoids have been detected in many different human tissues including the central nervous system 2~-2335,4z and human brain tumors. 7-~-'~ Products of cyclo-oxygenase modulate the replication of a variety of cells, with prostaglandin D2 demonstrating an antiproliferative effect on human neuroblastoma cells, 3~ mouse glioma cells, 1~ and cultured human glioma cells. 4~
T HE eicosanoids, derived from the precursor arachidonic acid, are metabolized via two pathways. The enzyme cyclo-oxygenase produces prostaglandins, prostacyclins, and thromboxanes while lipoxygenase produces hydroxyeicosatetraenoic acid derivatives (HETES) and the leukotrienes (Fig. 1 ). These compounds have been found to play a role in tumor promotion, cell proliferation, metastases, and immune surveillance. ~''7~ Eicosanoids have been detected in many different human tissues including the central nervous system 2~-2335,4z and human brain tumors. 7-~-'~ Products of cyclo-oxygenase modulate the replication of a variety of cells, with prostaglandin D2 demonstrating an antiproliferative effect on human neuroblastoma cells, 3~ mouse glioma cells, 1~ and cultured human glioma cells. 4~ Evidence is accumulating that implicates lipoxygenase products as positive or negative regulators of deoxyribonucleic acid (DNA) synthesis in normal lymphocyte mitogenesis, ~ psoriasis, 3~ neuroblastoma cells, 4~ erythropoietin-stimulated erythroid progenitor cells, 3 and prostate PC-3 cells.-" Leukotriene B4 may play a major role in lymphoma cell division because its addition to diluted cultures restores cell growth, while the lipoxygenase inhibitor nordihydroguaiaretic acid (NDGA) enhances glucocorticoid-induced lymphoma cell inhibition/' The inhibitor of eicosanoid biosynthesis, eicosatetraynoic acid (ETYA), decreased DNA synthesis in the malignant human monocyte-macrophage U937 line, a process that was partially reversed by leukotriene C4. 28 Recent work on in vivo inhibition of the lipoxygenase pathway demonstrated suppression of chemically induced carcinogenesis in the rat mammary gland 2~ and large bowel, 5 suggesting a role for these compounds in tumor initiation as well.
This study was designed to investigate the antiproliferative activity of the inhibitors of eicosanoid metabolism, NDGA or ETYA, on cultured rat and human glioma cells. The aim was to identify a relatively nontoxic drug capable of inhibiting glioma cell prolifera- tion, which could be administered to glioma patients to slow or even prevent further growth of their tumors.
There was marked inhibition of cell proliferation in glioma cells incubated with NDGA (a lipoxygenase inhibitor), and less dramatic inhibition of DNA synthesis in cells treated with ETYA (an inhibitor of lipoxygenase and cyclo-oxygenase activity). The effect of NDGA occurs rapidly (after 1 hour), is prolonged (lasts 72 hours) and reversible, and is not associated with cytotoxicity. This phenomenon was further evaluated using multiple glioma cell lines derived from rats and humans.
Materials and Methods

Cell Culture
The C6 rat glioma and T98G human glioma cell lines were obtained from the American Type Culture Collection (ATCC) at passage numbers 37 and 424, respectively. The human glioblastoma cell line A-172 was received from Dr. Herbert Englehard of Northwestern University, Chicago, Illinois, at the 10th passage over that received from the ATCC. The 9L rat glioma cell line was received from Dr. Marvin Barker of the Brain Tumor Research Center, San Francisco, California, and derived from the ninth culture passage. All four cell lines were studied within 10 passages in our laboratory and were negative on culture for Mycoplasma. The cell lines were maintained in 75-sq cm flasks at 37~ in a humidified atmosphere of 95% air/ 5 % CO2. The culture medium was Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum, 2 mM glutamine, 50 Mml penicillin, 50 #g/ml streptomycin, and 25 ml HEPES buffer. After confluence, the cell lines were passed to new flasks at a lower dilution using 0.25% trypsin and 20 mg% ethylenediaminetetra-acetic acid (EDTA) to detach the cells. The cells were separated with 5 mM EDTA in Hanks' balanced salt solution (HBSS) without calcium or magnesium for studies to determine cell number and viability. Cell number experiments were performed in D. E. Wilson, et aL triplicate using the tri-plate 100 x 15-mm Petri dish with cells incubated in DMEM plus 10% fetal bovine serum. Cell viability and cell number were determined in duplicate with a hemocytometer by counting a minimum of 100 cells in 0.04% trypan blue.
DNA Synthesis
The cultured glioma cell lines were detached during log phase growth using 5 mM EDTA in HBSS without calcium or magnesium. The ceils were counted, pelleted by centrifugation, and resuspended in fresh medium with 10% fetal bovine serum at a concentration of 2.5 to 5.0 x 105 cells/ml. A 0.2-ml aliquot of cell suspension was added to each well in a 96-well round-bottomed microtiter plate, resulting in 50,000 to 100,000 cells per well. After overnight incubation, the medium was gently suctioned from each well and one of the following agents solubilized in dimethyl sulfoxide (DMSO) was added to the wells in serum-free medium: NDGA; 5,8,11,14-ETYA; phenidone; 6,7 dihydroxycoumarin (esculetin); indomethacin; or acetylsalicylic acid. The final concentration of the vehicle DMSO did not exceed 0.25%, with control preparations receiving the same final concentration. This had no effect on 3H-thymidine incorporation. Each well received 1 uCi 3H-thymidine (5 Ci/mM) and the plates were incubated for 4 hours. Each data point represents the average result of five to seven wells for each concentration of inhibitor. Viability was determined to be greater than 90% by trypan blue exclusion after incubation. An automated multiple-sample harvester was used to wash the cells onto a Whatmann 934 glass-fiber filter with 0.9% saline. The filters were dried, cut, and placed in scintillation vials with 3.5 ml of scintillation fluid (Liquiscint).* Samples were counted on a liquid scintillation counter at 45% efficiency.t
Results
A concentration-dependent inhibition of DNA synthesis as measured by 3H-thymidine incorporation was demonstrated in all four glioma cell lines incubated for 4 hours in the presence of NDGA or ETYA (Fig. 2) . However, NDGA exerted a more profound inhibition of glioma cell DNA synthesis and was effective at lower concentrations. This inhibition was dependent upon concentration and was clearly present by 1 hour after incubation with 40 uM NDGA (Fig. 3) .
The results of DNA synthesis activity for three separate experiments on each glioma cell line in the presence of inhibitors were averaged as a percentage of control 3H-thymidine uptake (Fig. 4) . At 40 uM NDGA, the human A-172 and T98G glioma lines were suppressed to 5.6% + 1.3% and 5.0% 4-1.2% while rat * Liquiscint was supplied by National Diagnostics, Somerville, New Jersey.
t Liquid scintillation counter, Model LS 7500, manufactured by Beckman Instruments Inc., Fullerton, California. glioma lines C6 and 9L were inhibited to 1.8% + 0.6% and 3.1% ___ 0.9% of control 3H-thymidine uptake, respectively (means ___ standard error of the means) (Fig. 4) . Incubation with 80 uM ETYA inhibited both human lines to an average of 62% of control while the rat glioma lines were inhibited to 53% of control DNA synthesis activity. This inhibition was not associated with any loss of cell viability at any of the concentrations of NDGA or ETYA (10 uM to 80 uM), as judged by trypan blue exclusion studies. Prolonged incubation for 24 and 96 hours of the human A-172 and rat C6 glioma cell lines in the presence of I0 uM NDGA also failed to demonstrate any cytotoxicity (Table 1) . However, incubation for 24 hours suppressed cell proliferation in each glioma line, with some limited recovery in cell number occurring by 96 hours, most evident in the human A-172 line. The cell number increased from 2.2 x 105 to 14 x 10 ~ after 96 hours of incubation, while the control cells had reached confluence. However, a higher concentration of NDGA (100 uM) suppressed human A-172 glioma cell division for up to 72 hours of incubation (Fig. 5) , while the control cells demonstrated continued growth to confluence without loss of cell viability (data not shown).
The inhibition of cell proliferation observed in human glioma cells by NDGA was also found to be reversible (Table 2) , further arguing for a cytostatic mechanism and against a cytotoxic mechanism. The human A-172 glioma cells were incubated for 24 hours in 50 uM NDGA and no significant increase in cell number was observed, whereas the control cell number increased 3.4-fold. After resuspension of these inhibited cells in fresh medium, rapid recovery ensued with cell numbers increasing almost sixfold in the next 24 hours. A less complete recovery was observed after a 72-hour incubation in 100 uM NDGA with the cell number barely doubling over the next 72 hours while control cells were confluent. These studies also failed to demonstrate any loss of viability by a trypan blue exclusion test.
The effects of several concentrations of the cyclooxygenase inhibitors acetylsalicylic acid (12.5 ~tM and 25 uM) and indomethacin (1 ~M and 10 ~M) were studied on each glioma cell line (Fig. 6 ). An insignificant inhibition of DNA synthesis was noted that did not exceed the standard error except at the highest concentration of indomethacin in the C6 and 9L rat lines. The other in vitro inhibitors of eicosanoid metabolism, esculetin and phenidone, demonstrated only limited inhibition of DNA synthesis in each glioma cell line (Table 3) .
Discussion
Glioma cell DNA synthesis in the rat and human lines studied was markedly suppressed by NDGA (a lipoxygenase inhibitor) and to a lesser extent by ETYA (an inhibitor of lipoxygenase and cyclo-oxygenase activity). The selective cyclo-oxygenase inhibitors acetyl- * Values are mean (+ standard error of the mean) cell numbers (x 105) for three plates each. Glioma cells were incubated in triplicate using tfi-plate 100 x 15-mm Petri dishes, either in the presence or the absence of 50 uM nordihydroguaiaretic acid (NDGA). After 24 or 96 hours of incubation, the cell number and viability were determined in duplicate.
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Inhibition of cell proliferation without cytotoxicity*
FIG. 5. Inhibition of glioma cell proliferation with prolonged incubation in nordihydroguaiaretic acid (NDGA). Human A-172 glioma cells were plated on 100 • 15-mm tri-plate Petri dishes in triplicate and allowed to adhere overnight. Fresh medium with or without 100 uM NDGA was then added. No loss of viability occurred in any of the culture plates. Each data point is the mean __+ standard error of the mean for three plates, and each plate is counted in duplicate. Error bars not shown are encompassed by the data point. salicylic acid and indomethacin failed to exert a comparable suppression on DNA synthesis. Testing the inhibitory activity of the other proposed in vitro inhibitors of lipoxygenase activity, phenidone and esculetin, demonstrated only limited suppression of glioma cell DNA synthesis. Suppression of glioma cell DNA synthesis induced by NDGA, observed after a 4-hour incubation, corresponds to its antiproliferative effect, whereby 24 to 72 hours of incubation resulted in no significant increase in glioma cell number. This inhibition by NDGA occurs rapidly, with a significant effect seen as early 1 hour after incubation. The antitumor activity of NDGA in glioma cell cultures was not due to cytotoxicity. The NDGA-treated cells remained attached to the bottom of the wells or plates, did not take t Cells were incubated in triplicate with or without 50 uM nordihydroguaiaretic acid (NDGA) for 24 hours and then counted. The cells were placed in fresh medium, incubated for another 24 hours, and then counted again. Results are for three plates each.
Cells were incubated in duplicate 75-sq cm tissue culture flasks, with or without 100 uM NDGA for 72 hours, washed, and then counted. The cells were resuspended in fresh medium and incubated for another 72 hours before the final cell count was made. All cell counts were made in duplicate. Results are for two plates each.
FIG. 6.
Minimal effect on glioma cell DNA synthesis when treated with the specific cyclo-oxygenase inhibitors acetylsalicylic acid (ASA, 12.5 uM or 25 #M) or indometbacin (indo, 1 ~M or 10 uM). The experimental conditions are identical to those described for Fig. 2 . The left-most bar represents the lower concentration. Each data point is the average of five to seven wells (_+ standard error of the mean). 3H-TdR = 3H-thymidine.
up trypan blue, and were capable of resuming cell division once they were placed in fresh medium. In summary, N D G A suppression of glioma cell proliferation is rapid, prolonged, reversible, and (based on this evidence) cytostatic rather than cytotoxic.
The mechanism for N D G A -m e d i a t e d suppression of glioma cell proliferation is not known. The proposed activity of N D G A as an inhibitor of lipoxygenase activity 3v'38 is one possible explanation for its antitumor effect. The lipoxygenase pathway of arachidonic acid metabolism is illustrated in Fig. 1 . Evidence for lipoxygenase activity in the central nervous system has ac- Fig. 2. cumulated from a n u m b e r of sources. For example, leukotriene C4, B4, and E4 were detected in rat and gerbil brain 2~
and more recently a n u m b e r of HETES, including 5-HETE, 12-HETE, 15-HETE, and 9-HETE, have been identified in the brain of gerbils, 27"34 mice, ~ and rats. 26 Miyamoto, et al., 26 treated rat brain tissue with N D G A and found decreased synthesis of leukotrienes and five m o n o -H E T E S in a dose-dependent manner. It is possible that one of these lipoxygenase products is an important positive modulator for glioma cell growth. Evidence for this exists in other systems. For example, exogenous leukotriene B4 has been found to reverse corticosteroid-induced inhibition of normal lymphocyte proliferation ~5 and is identified as a critical growth factor in diluted l y m p h o m a cell cultures. ~ Lipoxygenase metabolites have also been detected by erythropoietin-stimulated erythroid progenitor cells with hydroperoxyeicosatetraenoic acid derivatives (HPETES) and possibly HETES implicated as second messengers for erythroid cell proliferation and differentiation? However, second messengers primarily exert their effects either via intracellular cyclic nucleotides or via phosphatidylinositol turnover and calcium mobilization with release of arachidonic acid. The mechanism by which the leukotrienes, HPETES, or even HETES might exert their effects as second messengers remains undefined.
Our results demonstrated that the inhibition of glioma cell D N A synthesis by ETYA, a competitive inhibitor of cyclo-oxygenase and lipoxygenase, was less dramatic than the almost complete cessation of D N A synthesis and cell division observed with N D G A . These two c o m p o u n d s may be inhibiting D N A synthesis by different mechanisms as well as affecting other enzyme systems. The other inhibitors of lipoxygenase activity, esculetin and phenidone, 13'3~ exerted less inhibition; however, these inhibitors have been identified primarily in in vitro systems, and their activity on in vivo lipoxygenase is unknown. Of the lipoxygenase inhibitors investigated, only N D G A has been studied in the central nervous system, and its suppression of lipoxygenase products is well documented. 2~26 Decreased penetration into glial cell membranes, biochemical differences in m e m b r a n e composition, or less susceptibility of glial lipoxygenase to these other inhibitors might also explain these observed differences in suppression. Furthermore, NDGA might be mediating its inhibition of glioma cell proliferation by mechanisms other than its effect on lipoxygenase activity. Burk and Woods s reported that NDGA inhibited aerobic and anaerobic glycolysis in Ehrlich ascites, K-2 ascites, and leukemia L-1210 cells in vitro; NDGA has also been identified as an inhibitor of electron transport. 29 The identification of a compound (for example, a leukotriene or HETE) capable of reversing the NDGA-mediated inhibition would further define the mechanism involved.
A natural product of the evergreen shrub Larrea divaricata, 12,14 NDGA is a potent antioxidant 37 and has been used as a food and pharmaceutical additive to prevent rancidity. 33 It was a part of the American diet until 1967 when better food antioxidants were found. Attesting to its low toxicity is its 50% lethal dose of 800 mg/kg in mice when given intraperitoneally. 36 No significant toxicity has been associated with supplementing the diet of rats for 2 years with NDGA, I1 the addition of NDGA to drinking water in hamsters, 24 or the intramuscular injections of NDGA, 400 mg/kg, in humans for up to 5 to 6 months. 4 The relatively nontoxic nature of NDGA combined with its dramatic inhibition of cultured glioma cell proliferation warrants further study in an in vivo glioma model.
